Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PR › Arecibo › NPI 1982958773
Physician

Retina Care PSC

Retina Care PSC was paid $4.32M by Medicaid between Jan 2018 and Dec 2024, across 18 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 26% of everything it billed.

33Billing provider infoRETINA CARE PSC
ARECIBO, PR 00612
33aNPI1982958773assigned 11/01/2012
33bProvider typeOphthalmology Physician
28Total paid$4.32M
24GClaims109,765
24DCodes billed18
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ophthalmology Physician providers in Puerto Rico

Rank by total paid#1 of 141
Median peer was paid$163K
This provider vs. median26×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201820,943$712K
201918,679$596K
202013,833$529K
202112,249$510K
202212,599$534K
202316,950$590K
2024incomplete14,512$845K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
67028 Intravitreal injection of a pharmacologic agent 26% 9,503 7,825 $1.12M
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 19% 17,361 15,208 $799K
92134 16% 29,522 25,289 $702K
67210 9.2% 1,074 923 $396K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 6.3% 2,998 2,472 $272K
92202 4.3% 12,607 10,779 $184K
67228 3.9% 343 311 $170K
92250 3.5% 7,138 6,331 $152K
92226 2.6% 11,955 5,822 $113K
92002 2.6% 2,589 2,379 $110K
67039 2.3% 62 52 $99K
C9257 Injection, bevacizumab, 0.25 mg 1.5% 7,126 5,955 $65K
6 more codes
92235 <1% 622 $38K
92225 <1% 2,739 $35K
J9035 Injection, bevacizumab, 10 mg <1% 706 $34K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 298 $30K
2023F 0% 1,417 $0.00
2022F 0% 1,705 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEMANUELLI ANZALOTTA, ANDRES (PRESIDENT)